Attachment G -- Reminder Letter

[AHRQ Letterhead]

[DATE]

Dear [Pharmacist Name]:

Two weeks ago, we mailed you a survey about the Phase I Demonstrations for the Pharmacy Quality Alliance (PQA). As a pharmacist who is participating in the demonstration at the [Demonstration Site Name] project, your participation is very important.

The primary purpose of this survey is to gain a better understanding of pharmacists’ perspectives on the demonstration project. In addition, we seek to understand pharmacists’ general beliefs about pharmacy quality improvement. Pharmacists across all five demonstration sites are being asked to complete the survey, so that the program can be evaluated at both the site and national level.

Your participation in this survey is voluntary, though we urge you to take advantage of this important opportunity to provide us with your feedback. Findings from this evaluation will be instrumental in informing future PQA efforts, and will directly inform future tests of the PQA measures.

The survey is being administered on behalf of AHRQ by an evaluation team at CNA Corporation in partnership with Thomas Jefferson University. Your name and contact information will not be shared with others outside of this evaluation team. Individual responses will be kept confidentialYour responses will be kept confidential to the extent permitted by law, including AHRQ’s confidentiality statute, 42 USC 299c-3(c); results will be shared only in aggregate with PQA leadership and your demonstration site. The survey has been reviewed by the Institutional Review Board at Thomas Jefferson University and approved for exemption.

On behalf of AHRQ, the evaluation team, and your demonstration site, we appreciate your participation in the project and hope that you will return your completed survey as soon as possible. If you have questions or need another copy of the survey, please contact [insert name, phone number and email address of evaluation team contact]. If you have already returned your completed survey, please disregard this letter.

Thank you for your time.

Sincerely,

[signature]

Linda Greenberg, PhD

Federal Project Officer, Agency for Healthcare Research and Quality (AHRQ) Carolyn Clancy, MD

Director of the Agency for Healthcare Research and Quality (AHRQ)